Erratum to “Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era” AmJMed, 133(11); 1254–1261

Published:January 09, 2021DOI:
      The publisher regrets that the author affiliations as presented in the published article were incorrect. The correct list of authors and their proper affiliations appears above.
      The publisher apologizes for any inconvenience caused.

      Linked Article

      • Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era
        The American Journal of MedicineVol. 133Issue 11
        • Preview
          It is clear that existing cardiovascular disease is a major risk factor for COVID-19 and related adverse outcomes. In addition to acute respiratory syndrome, a large cohort also develop myocardial or vascular dysfunction, in part from inflammation and renin angiotensin system activation with increased sympathetic outflow, cardiac arrhythmias, ischemia, heart failure, and thromboembolic complications that portend poor outcomes related to COVID-19. We summarize recent information for hospitalists and internists on the front line of this pandemic regarding its cardiovascular impacts and management and the need for cardiovascular consultation.
        • Full-Text
        • PDF